Litcius/Paper detail

Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox

Lucy Deng, Laura López, Catherine Glover, Patrick Cashman, Renee Reynolds, Kristine Macartney, Nicholas Wood

2023JAMA27 citationsDOIOpen Access PDF

Abstract

This study uses data collected by Australia’s vaccine safety surveillance system to examine the adverse event profile of the modified vaccinia Ankara–Bavarian Nordic vaccine.

Topics & Concepts

MedicineVacciniaImmunizationAdverse effectModified vaccinia AnkaraVirologySmallpox vaccineImmunologyImmune systemInternal medicineRecombinant DNAChemistryGeneBiochemistrySARS-CoV-2 and COVID-19 ResearchPoxvirus research and outbreaksBacillus and Francisella bacterial research
Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox | Litcius